Skip to main content

PERRIGO Co plc

For the period ended Mar 30, 2024. Filed May 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 30, 2024 · Filed May 7, 2024

PRGO$16.95+6.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Restructuring Charges

NOTE 13 -RESTRUCTURING CHARGES

We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, asset impairments, and related consulting fees. The following reflects our restructuring activity (in millions):

Three Months Ended
March 30, 2024
Supply Chain ReinventionHRA Pharma IntegrationProject EnergizeOther InitiativesTotal
Beginning balance$0.7$6.8$2.9$1.8$12.2
Additional charges2.60.141.40.244.3
Payments(2.4)(0.3)(6.9)(1.1)(10.7)
Non-cash adjustments——(4.8)—(4.8)
Ending balance$0.9$6.6$32.6$0.9$41.0
Three Months Ended
April 1, 2023
Supply Chain ReinventionHRA Pharma IntegrationOther InitiativesTotal
Beginning balance$2.2$13.3$4.3$19.8
Additional charges2.60.8—3.4
Payments(4.4)(2.6)(1.0)(8.0)
Non-cash adjustments—0.30.10.4
Ending balance$0.4$11.8$3.4$15.6

The charges incurred during the three months ended March 30, 2024 and April 1, 2023 were primarily associated with actions taken on supply chain restructuring, Project Energize and HRA Pharma integration activities.

Of the amount recorded during the three months ended March 30, 2024, $15.5 million was related to our CSCI segment and $16.5 million related to our CSCA segment, and $12.3 million was related to our Unallocated segment. For all segments, amounts were due primarily to Project Energize. Of the amount recorded during the three months ended April 1, 2023, $0.9 million was related to our CSCI segment, and $1.2 million was related to our CSCA

Note 13

segment, and $1.3 million was related to our Unallocated segment. For all segments, amounts were due primarily to supply chain restructuring.

There were no other material restructuring programs for the periods presented. All charges are recorded in Restructuring expense on the Condensed Consolidated Statements of Operations. The remaining $41.0 million liability for employee severance benefits and consulting fees is expected to be mostly paid within the next year.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.